Serious adverse event: late neurotropic disease associated with yellow fever vaccine
Einstein (São Paulo), 2020 The yellow fever is a systemic disease that was under control due to the effective campaigns against the vector and promotion of vaccines programs. However, since 1999, outbreaks appeared because of inefficient control of the vector, and led to the need ...
Henrique Souza Barros de Oliveira +5 more
doaj +2 more sources
The Hajj 2019 Vaccine Requirements and Possible New Challenges [PDF]
, 2019 Each year millions of pilgrims perform the annual Hajj from more than 180 countries around the world. This is one of the largest mass gathering events and may result in the occurrence and spread of infectious diseases.
Al-Tawfiq, Jaffar A., Memish, Ziad A.
core +1 more source
Novel approaches, including systems biology, to HIV vaccine research and development: Report from a Global HIV Vaccine Enterprise Working Group [PDF]
, 2010 The Global HIV Vaccine Enterprise convened a two-day workshop on August 10-11 2009, at the Fred Hutchison Cancer Research Center offices in Seattle, WA, to discuss the application of novel approaches,including systems biology, to HIV vaccine research and
Alan Aderem +3 more
core +5 more sources
Visualization of yellow fever virus infection in mice using a bioluminescent reporter virus
Emerging Microbes and Infections, 2021 Yellow fever virus (YFV) is a re-emerging flavivirus, which can lead to severe clinical manifestations and high mortality, with no specific antiviral therapies available.
Hao-Long Dong +9 more
doaj +1 more source
Narcolepsy Following Yellow Fever Vaccination: A Case Report [PDF]
, 2016 Narcolepsy with cataplexy is a rare, but important differential diagnosis for daytime sleepiness and atonic paroxysms in an adolescent. A recent increase in incidence in the pediatric age group probably linked to the use of the Pandemrix influenza ...
Deb K. Pal +3 more
core +3 more sources
Vaccines, 2019 Yellow fever is a potentially fatal, mosquito-borne viral disease that appears to be experiencing a resurgence in endemic areas in Africa and South America and spreading to non-endemic areas despite an effective vaccine.
Kay M. Tomashek +3 more
doaj +1 more source
Yellow Fever Virus Vaccine–associated Deaths in Young Women
Emerging Infectious Diseases, 2011 Yellow fever vaccine–associated viscerotropic disease is a rare sequela of live-attenuated virus vaccine. Elderly persons and persons who have had thymectomies have increased susceptibility.
Stephen J. Seligman
doaj +1 more source
Vaccine coverage and determinants of incomplete vaccination in children aged 12-23 months in dschang, west region, cameroon: a cross-sectional survey during a polio outbreak [PDF]
, 2015 Inadequate immunization coverage with increased risk of vaccine preventable diseases outbreaksremains a problem in Africa. Moreover, different factors contribute to incomplete vaccination status. This study wasperformed in Dschang (West Region, Cameroon),
Biguioh, Rodrigue Mabvouna +8 more
core +2 more sources
An Atypical Local Vesicular Reaction to the Yellow Fever Vaccine
Vaccines, 2017 Yellow fever vaccine is a live attenuated viral inoculation indicated for patients traveling to endemic areas. The vaccine is generally well tolerated with minimal adverse effects.
Robert H. Wauters +2 more
doaj +1 more source
Yellow Fever outbreaks in unvaccinated populations, Brazil, 2008-2009.
PLoS Neglected Tropical Diseases, 2014 Due to the risk of severe vaccine-associated adverse events, yellow fever vaccination in Brazil is only recommended in areas considered at risk for disease.
Alessandro Pecego Martins Romano +8 more
doaj +1 more source